EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders | MicrobiomeTrials← Back to trialsNCT07727356
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-03Est. Completion: 2031-08
Enrollment target: 100 participants Locations- University Hospital Zürich, Zurich, Switzerland
Other microbiome trials you might be interested in
Opioid UsePainHypogonadism, Male
The aim of this trial is to evaluate whether testosterone replacement results in greater improvement in pain perception,…
Boston, United StatesEst. completion Sep 30, 2027
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple LocationsEst. completion Jan 12, 2027
Phase 3
Recruiting
Central Precocious Puberty
The primary objective of this study is to evaluate the efficacy of Debio 4326 in suppressing serum luteinizing hormone (…
San Diego, United StatesEst. completion Oct 2026